Endpoints

Endpoints

By ALS TDIBusinessNewsScienceNon-Profit
Download on the App Store

Endpoints episodes

  • Can Regulatory T Cells (Tregs) help treat ALS?
    In this episode of the Endpoints, Dr. Steve Perrin, CEO at the ALS Therapy Development Institute, talks about Regulatory-T cells or Tregs as a potential treatment for ALS. Regulatory T cells are a type of lymphocyte, or white blood cell which play an immunosuppressive role in our bodies. 
    Access all episodes of the Endpoints Podcast.
    Support the show.
    11 min
  • What are Antisense oligonucleotides?
    In this episode Dr. Steve Perrin, CEO at the ALS Therapy Development Institute and Dr. Fernando Vieira, CSO at ALS TDI join us to talk about Antisense Oligonucleotides (ASOs). ASOs are molecules, mostly DNA, that are specifically designed to target and suppress the expression of a specific gene. They work by binding directly to messenger RNA (mRNA) and block it from producing a specific protein.
    Access all episodes of the Endpoints Podcast.
    Support the show.
    12 min
  • NurOwn and the Hope for Stem Cells in ALS?
    On this episode of the Endpoints, Dr. Steve Perrin, CEO at ALS TDI answers questions about one of the most talked about clinical trials in ALS at the moment, Brainstorm Cell Therapeutics’ NurOwn, a proposed stem-cell-based treatment.
    13 min

About Endpoints

From the publisher's feed

The Endpoints Podcast features guests from the ALS community, including people living with ALS, researchers, advocates and fundraisers. Each episode cuts to the chase with short, digestible conversations about the latest research at ALS TDI and the most closely watched ALS clinical trials as well as stories from people living with ALS with their thoughts on research, healthcare and their journey with ALS.

More shows like Endpoints

The Daily by The New York Times

The Daily

111,799 Listeners

The Couple Shift | An ALS Story by Maria Aleandra and Julian Rodriguez

The Couple Shift | An ALS Story

40 Listeners